“unlocking tomorrow’s cures”...ds 11 76 ajv sanlva santvn q £ 6 jvlnîn( dla (puny u:...
TRANSCRIPT
![Page 1: “Unlocking Tomorrow’s Cures”...dS 11 76 aJV sanlVA santvn q £ 6 JVlnîn( dlA (puny u: Clinical trials begin to test telcagepant and other gepants in acute migraine Overview](https://reader033.vdocuments.us/reader033/viewer/2022041801/5e51afdd09cbf337a32c9e62/html5/thumbnails/1.jpg)
1
Migraine & CGRP: a new era for patientsAuthor: Prof Jan Versijpt, MD PhD Date: May 24, 2018
“Unlocking Tomorrow’s Cures”
![Page 2: “Unlocking Tomorrow’s Cures”...dS 11 76 aJV sanlVA santvn q £ 6 JVlnîn( dlA (puny u: Clinical trials begin to test telcagepant and other gepants in acute migraine Overview](https://reader033.vdocuments.us/reader033/viewer/2022041801/5e51afdd09cbf337a32c9e62/html5/thumbnails/2.jpg)
![Page 3: “Unlocking Tomorrow’s Cures”...dS 11 76 aJV sanlVA santvn q £ 6 JVlnîn( dlA (puny u: Clinical trials begin to test telcagepant and other gepants in acute migraine Overview](https://reader033.vdocuments.us/reader033/viewer/2022041801/5e51afdd09cbf337a32c9e62/html5/thumbnails/3.jpg)
Stovner, IHC 2009
![Page 4: “Unlocking Tomorrow’s Cures”...dS 11 76 aJV sanlVA santvn q £ 6 JVlnîn( dlA (puny u: Clinical trials begin to test telcagepant and other gepants in acute migraine Overview](https://reader033.vdocuments.us/reader033/viewer/2022041801/5e51afdd09cbf337a32c9e62/html5/thumbnails/4.jpg)
A) n 5
B) 4 - 72 h
C) 1.
2.
3. ++ / +++
4.
1. +
2.
2/4
1/2
D)
![Page 5: “Unlocking Tomorrow’s Cures”...dS 11 76 aJV sanlVA santvn q £ 6 JVlnîn( dlA (puny u: Clinical trials begin to test telcagepant and other gepants in acute migraine Overview](https://reader033.vdocuments.us/reader033/viewer/2022041801/5e51afdd09cbf337a32c9e62/html5/thumbnails/5.jpg)
![Page 6: “Unlocking Tomorrow’s Cures”...dS 11 76 aJV sanlVA santvn q £ 6 JVlnîn( dlA (puny u: Clinical trials begin to test telcagepant and other gepants in acute migraine Overview](https://reader033.vdocuments.us/reader033/viewer/2022041801/5e51afdd09cbf337a32c9e62/html5/thumbnails/6.jpg)
4
5
6
7Severe migraine
Active psychosis
Dementia
Quadriplegia
Unipolar major depression
Blindness
Paraplegia
Mild mental retardation
Down syndrome
Incr
eas
ing
dis
abili
ty
Below-the-knee amputation
Deafness
Menken M. Arch Neurol. 2000;57:418-420.
Disability Class 4
Disability Class 5
Disability Class 6
Disability Class 7
![Page 7: “Unlocking Tomorrow’s Cures”...dS 11 76 aJV sanlVA santvn q £ 6 JVlnîn( dlA (puny u: Clinical trials begin to test telcagepant and other gepants in acute migraine Overview](https://reader033.vdocuments.us/reader033/viewer/2022041801/5e51afdd09cbf337a32c9e62/html5/thumbnails/7.jpg)
![Page 8: “Unlocking Tomorrow’s Cures”...dS 11 76 aJV sanlVA santvn q £ 6 JVlnîn( dlA (puny u: Clinical trials begin to test telcagepant and other gepants in acute migraine Overview](https://reader033.vdocuments.us/reader033/viewer/2022041801/5e51afdd09cbf337a32c9e62/html5/thumbnails/8.jpg)
![Page 9: “Unlocking Tomorrow’s Cures”...dS 11 76 aJV sanlVA santvn q £ 6 JVlnîn( dlA (puny u: Clinical trials begin to test telcagepant and other gepants in acute migraine Overview](https://reader033.vdocuments.us/reader033/viewer/2022041801/5e51afdd09cbf337a32c9e62/html5/thumbnails/9.jpg)
![Page 10: “Unlocking Tomorrow’s Cures”...dS 11 76 aJV sanlVA santvn q £ 6 JVlnîn( dlA (puny u: Clinical trials begin to test telcagepant and other gepants in acute migraine Overview](https://reader033.vdocuments.us/reader033/viewer/2022041801/5e51afdd09cbf337a32c9e62/html5/thumbnails/10.jpg)
Ann Neurol 1990;28(2):183-7Brain 1994;117( Pt 3):427-34
![Page 11: “Unlocking Tomorrow’s Cures”...dS 11 76 aJV sanlVA santvn q £ 6 JVlnîn( dlA (puny u: Clinical trials begin to test telcagepant and other gepants in acute migraine Overview](https://reader033.vdocuments.us/reader033/viewer/2022041801/5e51afdd09cbf337a32c9e62/html5/thumbnails/11.jpg)
![Page 12: “Unlocking Tomorrow’s Cures”...dS 11 76 aJV sanlVA santvn q £ 6 JVlnîn( dlA (puny u: Clinical trials begin to test telcagepant and other gepants in acute migraine Overview](https://reader033.vdocuments.us/reader033/viewer/2022041801/5e51afdd09cbf337a32c9e62/html5/thumbnails/12.jpg)
![Page 13: “Unlocking Tomorrow’s Cures”...dS 11 76 aJV sanlVA santvn q £ 6 JVlnîn( dlA (puny u: Clinical trials begin to test telcagepant and other gepants in acute migraine Overview](https://reader033.vdocuments.us/reader033/viewer/2022041801/5e51afdd09cbf337a32c9e62/html5/thumbnails/13.jpg)
EfficacyShort-term safety / tolerance
SuperiorityEfficacy in treatment-refractory patients
Long-term safety
![Page 14: “Unlocking Tomorrow’s Cures”...dS 11 76 aJV sanlVA santvn q £ 6 JVlnîn( dlA (puny u: Clinical trials begin to test telcagepant and other gepants in acute migraine Overview](https://reader033.vdocuments.us/reader033/viewer/2022041801/5e51afdd09cbf337a32c9e62/html5/thumbnails/14.jpg)
14
Q&A
THANK YOU!